IDRI Names New Chief Operating Officer and Chief Scientific Officer

April 6th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 6, 2018: As IDRI (Infectious Disease Research Institute) celebrates its 25th anniversary in 2018, the organization is developing a strategic plan to hone current strengths while embarking upon bold new initiatives including next generation [...]

IDRI Partners to Develop a New Vaccine to Prevent Transmission of Malaria

March 29th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 29, 2018: The Global Health Innovative Technology Fund (GHIT) has awarded the University of Florida (UF) and partners, including IDRI (Infectious Disease Research Institute), $3.2 million to advance a promising vaccine to prevent transmission [...]

IDRI TB Vaccine Candidate Shows Success in Initial Trial

March 24th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 24, 2018 : Researchers at IDRI (Infectious Disease Research Institute), the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT) and Aeras have released the first results from a clinical trial [...]

IDRI Receives $3.8 Million for TB Drug Discovery

March 23rd, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | March 23, 2018: IDRI’s tuberculosis drug discovery efforts continue to expand with a recently awarded grant extension of $3.8 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya [...]

Dan Stinchcomb: The Passing of a Global Health Leader

March 14th, 2018|Blog|

The world lost a tremendous advocate for global health with the passing of Dan Stinchcomb, PhD, IDRI’s Chief Scientific Officer, who died Feb. 21 after a brief illness. In a short time, he made a tremendous impact on IDRI’s work [...]

Here’s One Thing to Do on Sunday

January 26th, 2018|Blog|

As World Leprosy Day rolls around this year on Sunday, Jan. 28, we have much to be excited about from the scientific standpoint. In October, IDRI announced that our promising leprosy vaccine candidate – the first vaccine developed specifically for [...]

IDRI’s 6th annual Geek Gift Guide

December 6th, 2017|Blog|

The clock is ticking; the pressure is on. It’s time to buy holiday gifts! The question is: what are you going to get your favorite geek? As a scientific organization, IDRI is full of self-proclaimed geeks who have a few [...]

TB and Antimicrobial Resistance Go Hand-in-Hand

November 13th, 2017|Blog|

Every year the World Health Organization releases its global report on tuberculosis. For the past few years, this has provided sobering reading. Tuberculosis is the biggest killer among infectious diseases, surpassing both AIDS and malaria. In 2016, there were 1.7 [...]

Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

Load More